Article
CHST9 rs1436904 genetic variant contributes to prognosis of triple-negative breast cancer.
Scientific reports - 18 Sept 2017
Yuan Jupeng, Zhang Nasha, Zhu Hui, Liu Jibing, Xing Huaixin, Ma Fei, Yang Ming
Abstract excerpt
Triple-negative breast cancer (TNBC) refers to one aggressive histological subtype of breast cancer with high heterogeneity and poor prognosis after standard therapy. Lack of clearly established molecular mechanism driving TNBC progression makes personalized therapy more difficult. Thus, identification of genetic variants associated with TNBC prognosis will show clinic significance for individualized treatments....
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
